Results 201 to 210 of about 57,995 (263)

Lanreotide for the treatment of patients with disseminated high-grade neuroendocrine tumors: the experience of application in case of unsatisfactory tolerability of octreotide

, 2016
G. S. Emelyanova, А. Е. Кузьминов, Н. Ф. Орел, А. С. Одинцова, А. А. Маркович, А. А. Кузнецова, Vera Gorbunova   +6 more
openalex   +1 more source

Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14 [PDF]

, 2011
Kathleen I. Pritchard, Lois E. Shepherd, Judith‐Anne W. Chapman, B. Norris, Jacques Cantin, Paul E. Goss, Susan Dent, David Walde, Ted Vandenberg, B. Findlay, Susan E. O’Reilly, Carolyn F. Wilson, Lei Han, Ettie Piura, Timothy J. Whelan, Michaël Pollak   +15 more
openalex   +1 more source

Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo

Drug Delivery, 2016
Huipeng Li, Dongfen Yuan, Minjie Sun, Q. Ping   +3 more
semanticscholar   +1 more source

Dosing patterns, healthcare resource utilization and costs among acromegaly patients who consistently use lanreotide and injectable octreotide. [PDF]

J Comp Eff Res
Quock TP, Chang E, Das AK, Speller A, Tarbox MH, Rattana SK, Paulson IE, Broder MS.   +7 more
europepmc   +1 more source

Diagnostic performance and clinical impact of ¹⁸F-AlF-NOTA-octreotide in a large cohort of patients with neuroendocrine neoplasms: A prospective single-center study [PDF]

Guozhu Hou, Xin Cheng, Yi Yang, Dongbing Zhao, Guiqi Wang, Hong Zhao, Rong Zheng, Xuejuan Wang, Xiaoyuan Chen, Yihebali Chi, Jingjing Zhang   +10 more
openalex   +1 more source

Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. [PDF]

, 1996
R. Arnold, Michael Trautmann, W. Creutzfeldt, R Benning, Mayah Benning, Christoph Neuhaus, R Jürgensen, Ken Stein, H. Schäfer, Christian Bruns, Hans J. Dennler   +10 more
openalex   +1 more source

Pathological validation of ¹⁸F-AlF-NOTA-octreotide PET/CT for neuroblastoma. [PDF]

Sci Rep
Liu Y, Ma Y, Wang H, Sun Y, Zheng F, Zhao M, Sun X.   +6 more
europepmc   +1 more source

3D spheroid defects in NPHP knockdown cells are rescued by the somatostatin receptor agonist octreotide

, 2012
Amiya K. Ghosh, Toby W. Hurd, Friedhelm Hildebrandt   +2 more
openalex   +2 more sources

Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRT. [PDF]

Cancers (Basel)
Chauhan A, Halfdanarson TR, Vijayvergia N.   +2 more
europepmc   +1 more source

Central blood volume in cirrhosis [PDF]

, 1993
Bendtsen, Flemming, Gerbes, Alexander L., Henriksen, Jens H.   +2 more
core   +1 more source